# The Importance of Cervical Cancer Screening in the U.S.

- Show: [Global Medical Device Podcast](https://hardwarepodcasts.com/podcast/global-medical-device-podcast)
- Published: 2022-11-04
- Length: 19m
- Episode: 288
- Page: https://hardwarepodcasts.com/podcast/global-medical-device-podcast/2022-11-04-the-importance-of-cervical-cancer-screening-in-the-u-s
- Listen: https://podcast.greenlight.guru/episode/the-importance-of-cervical-cancer-screening-in-the-u-s

## Summary

Chris Beddard, VP of US Marketing at BD, discusses the BD Onclarity HPV assay, an FDA-approved diagnostic tool featuring extended genotyping to help clinicians manage cervical cancer risk. She explains the rigorous development process, including multi-year clinical trials for three testing paradigms, and highlights the significant drop in screening during the pandemic. Beddard emphasizes the importance of market shaping, reimbursement alignment, and global health initiatives, particularly in Africa, to ensure patients receive timely and precise care.

## Chapters

- [0:02](https://hardwarepodcasts.com/podcast/global-medical-device-podcast/2022-11-04-the-importance-of-cervical-cancer-screening-in-the-u-s#t=2) Introduction: Chris Beddard and BD's Women's Health Portfolio
- [1:51](https://hardwarepodcasts.com/podcast/global-medical-device-podcast/2022-11-04-the-importance-of-cervical-cancer-screening-in-the-u-s#t=111) BD's Product Selection and Cross-Functional Development Process
- [4:29](https://hardwarepodcasts.com/podcast/global-medical-device-podcast/2022-11-04-the-importance-of-cervical-cancer-screening-in-the-u-s#t=269) BD Onclarity HPV Assay and Extended Genotyping Features
- [8:00](https://hardwarepodcasts.com/podcast/global-medical-device-podcast/2022-11-04-the-importance-of-cervical-cancer-screening-in-the-u-s#t=480) Clinical Trials and FDA Approval for Three Testing Paradigms
- [9:22](https://hardwarepodcasts.com/podcast/global-medical-device-podcast/2022-11-04-the-importance-of-cervical-cancer-screening-in-the-u-s#t=562) HPV Prevalence, Statistics, and the Importance of Screening
- [11:11](https://hardwarepodcasts.com/podcast/global-medical-device-podcast/2022-11-04-the-importance-of-cervical-cancer-screening-in-the-u-s#t=671) Pandemic Impact on Screening Rates and Healthcare Access
- [14:38](https://hardwarepodcasts.com/podcast/global-medical-device-podcast/2022-11-04-the-importance-of-cervical-cancer-screening-in-the-u-s#t=878) Advice on Market Shaping, Reimbursement, and Commercialization

## Topics

- [Medical & health devices](https://hardwarepodcasts.com/topic/medical-devices)
- [Validation & product-market fit](https://hardwarepodcasts.com/topic/validation-and-product-market-fit)
- [Pricing, margins & unit economics](https://hardwarepodcasts.com/topic/pricing-and-unit-economics)
- [Scaling production](https://hardwarepodcasts.com/topic/scaling-production)

## Most relevant to

large enterprises

## Mentioned

- BD (company)
- BD Onclarity HPV assay (product)
- FDA (other)
- CDC (other)
- American Cancer Society (other)

## Citing this page

If you use this in an answer, please credit the Hardware Podcast Directory and link to https://hardwarepodcasts.com/podcast/global-medical-device-podcast/2022-11-04-the-importance-of-cervical-cancer-screening-in-the-u-s. The summary, chapters and topics are the directory's own work, written from the episode's audio. The episode itself, its title and its audio belong to Global Medical Device Podcast.